143 related articles for article (PubMed ID: 3628222)
1. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
[TBL] [Abstract][Full Text] [Related]
2. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
3. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
[TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
von Schönfeld J; Rünzi M; Goebell H; Müller MK
Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
[TBL] [Abstract][Full Text] [Related]
7. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
[TBL] [Abstract][Full Text] [Related]
8. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
Miyasaka K; Nakamura R; Kitani K
J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
Lhoste EF; Roebuck BD; Longnecker DS
Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
[TBL] [Abstract][Full Text] [Related]
10. Effect of atropine on feedback regulation of pancreatic secretion in rats.
Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G
Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
[TBL] [Abstract][Full Text] [Related]
12. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
13. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
15. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R
Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288
[TBL] [Abstract][Full Text] [Related]
20. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
